graphic
abstract
highlight
ebola
glycoprotein
mutant
aros
earli
domin
west
african
epidem
infect
human
cell
effici
ancestr
glycoprotein
increas
infect
specif
primat
cell
weakli
associ
increas
mortal
epidem
ebola
viru
ebov
envelop
filoviru
negativesens
singlestrand
rna
genom
caus
sporad
outbreak
lethal
hemorrhag
fever
human
feldmann
geisbert
kuhn
et
al
ebov
identifi
human
pathogen
bowen
et
al
johnson
et
al
pattyn
et
al
high
casefat
rate
selflimit
natur
evd
outbreak
suggest
evd
zoonosi
bausch
schwarz
feldmann
geisbert
detect
antiebov
antibodi
ebov
rna
sever
fruit
bat
speci
central
africa
make
lead
candid
anim
reservoir
hayman
et
al
leroy
et
al
ng
et
al
pourrut
et
al
pourrut
et
al
histor
ebola
viru
diseas
evd
outbreak
geograph
limit
resolv
hundr
case
cdc
contrast
epidem
caus
ebov
makona
variant
much
larger
began
guinea
baiz
et
al
spread
sierra
leon
liberia
infect
peopl
control
although
sociolog
epidemiolog
factor
central
epidem
unpreced
scale
alexand
et
al
research
also
examin
possibl
genet
chang
uniqu
ebov
makona
play
role
date
experi
ebov
makona
detect
evid
increas
replic
phenotyp
studi
primat
immunodefici
mice
exampl
fail
detect
increas
virul
ebov
makona
compar
ebov
mayinga
refer
isol
marzi
et
al
smither
et
al
likewis
ebov
makona
immunomodulatori
protein
inhibit
interferon
signal
extent
analog
protein
encod
ebov
previou
outbreak
dunham
et
al
studi
howev
examin
earli
refer
ebov
makona
isol
kissidoug
guinea
address
possibl
chang
viru
cours
epidem
larg
number
humantohuman
transmiss
ebov
makona
evd
epidem
provid
greater
opportun
ebov
adapt
human
host
previou
outbreak
expect
rna
viru
monitor
cours
evd
epidem
reveal
mutat
throughout
genom
ebov
makona
carrol
et
al
gire
et
al
simonlorier
et
al
howev
except
mucinlik
domain
glycoprotein
gp
diversifi
select
host
humor
immun
system
ebov
genom
exhibit
purifi
select
park
et
al
although
nonsynonym
mutat
detect
epidem
probabl
littl
effect
viral
fit
possibl
mutat
prolifer
confer
advantag
viru
one
candid
cladedefin
substitut
ebov
makona
gp
emerg
time
epidem
number
evd
case
increas
exponenti
mutat
particularli
intrigu
locat
receptorbind
domain
ebov
gp
describ
effort
determin
whether
confer
replic
advantag
viru
get
broadest
possibl
perspect
ebov
sequenc
evolut
took
place
evd
epidem
gener
phylogenet
tree
use
ebov
makona
sequenc
nearcomplet
genom
avail
tabl
tree
demonstr
two
distinct
lineag
figur
first
lineag
consist
sequenc
larg
confin
region
around
conakri
guinea
second
lineag
form
monophylet
clade
compris
genom
sampl
march
august
second
lineag
includ
ebov
countri
affect
epidem
larg
defin
two
mutat
nonsynonym
ctot
substitut
nucleotid
result
substitut
synonym
ttoc
substitut
nucleotid
encod
amino
acid
viral
np
addit
present
vast
major
ebov
infect
epidem
mutant
interest
residu
locat
receptor
bind
interfac
gong
et
al
wang
et
al
two
lineag
plot
accord
date
countri
sampl
figur
first
sampl
guinea
march
next
sampl
may
sierra
leon
june
lineag
sampl
guinea
number
evd
case
caus
liberia
sierra
leon
grew
rapidli
summer
fall
appar
contribut
first
ancestr
lineag
fall
ebov
reintroduc
guinea
liberia
sierra
leon
result
burst
addit
case
carrol
et
al
quick
et
al
simonlorier
et
al
detect
addit
amino
acid
substitut
ebov
makona
gp
popul
though
none
approach
preval
major
pursu
locat
mucinlik
domain
dispens
entri
target
cell
chandran
et
al
jeffer
et
al
kaletski
et
al
schornberg
et
al
instead
focus
sublineag
atog
chang
nucleotid
result
doubl
mutant
figur
asid
frequent
observ
nonsynonym
mutat
outsid
mucinlik
domain
four
isol
sublineag
possess
addit
atog
substitut
nucleotid
result
tripl
mutant
mutant
studi
describ
natur
occur
gp
mutant
evalu
abil
infect
cell
place
mammalian
express
plasmid
contain
gene
encod
ebov
makona
gp
plasmid
construct
ancestr
sequenc
mutant
combin
addit
singl
mutant
construct
although
mutat
never
observ
independ
epidem
express
plasmid
use
gener
ebov
gppseudotyp
lentivir
virion
particl
bear
gfp
report
gene
equal
volum
supernat
use
transduc
human
osteosarcoma
cell
line
confirm
construct
gener
compar
amount
particl
measur
revers
transcriptas
activ
supernat
hr
later
transduct
effici
gp
assess
measur
percent
gfpposit
cell
flow
cytometri
lentivirus
bear
produc
gfpposit
cell
particl
bear
ancestr
gp
figur
contrast
pseudotyp
bear
either
singl
mutant
produc
gfpposit
cell
rate
similar
ancestr
gp
determin
whether
observ
infect
differ
particular
cell
similar
transduct
perform
cell
target
cell
cell
increas
infect
observ
lentivir
particl
pseudotyp
figur
statist
signific
chang
observ
transduct
use
either
singl
mutant
dendrit
cell
dc
target
ebov
replic
vivo
earli
later
stage
infect
geisbert
et
al
therefor
look
effect
gp
mutant
infect
critic
cell
type
figur
human
monocytederiv
dc
gener
eight
blood
donor
cell
challeng
ancestr
mutant
ebov
gppseudotyp
lentivir
vector
compar
ancestr
gp
gp
significantli
enhanc
infect
individu
substitut
either
effect
less
infect
amino
acid
substitut
introduc
ebov
gp
may
alter
rate
protein
product
process
protein
stabil
protein
incorpor
virion
determin
whether
properti
chang
ebov
gp
mutant
amount
ancestr
versu
mutant
gp
present
ebov
gppseudotyp
lentivirus
compar
ebov
gppseudotyp
lentivirus
enrich
acceler
sucros
cushion
virionassoci
protein
analyz
western
blot
use
polyclon
antiserum
epitop
tag
append
carboxyl
terminu
gp
gp
cleav
furin
two
compon
western
blot
show
two
distinct
band
one
band
kda
consist
size
fulllength
gp
either
uncleav
furin
coval
bound
disulfid
linkag
figur
second
band
kda
consist
furinprocess
product
band
intens
compar
intens
lentivirion
capsid
core
gp
show
equival
level
incorpor
particl
indic
enhanc
infect
observ
human
cell
ebov
gp
due
differ
protein
synthesi
process
gp
incorpor
lentivir
particl
ebov
matrix
protein
suffici
drive
assembl
bud
filament
viruslik
particl
vlp
produc
cell
plasma
membran
geisbert
jahrl
see
also
tabl
data
noda
et
al
also
suffici
incorpor
ebov
gp
virion
membran
result
particl
capabl
bona
fide
receptormedi
entri
target
cell
cytoplasm
facilit
quantit
ebov
gpmediat
entri
ebov
fuse
blactamas
use
gener
vlp
vlp
use
infect
target
cell
subsequ
target
cell
load
fluorogen
substrat
trap
within
target
cell
cytoplasm
substrat
cleav
gp
success
attach
bind
trigger
fusion
releas
cytoplasm
manicassami
rong
tschern
et
al
experiment
system
requir
transcript
report
gene
therefor
directli
test
whether
ebov
gp
mutant
increas
abil
ebov
core
enter
target
cell
cytoplasm
blactamasecontain
vlp
bear
ancestr
mutant
ebov
gp
incub
target
cell
cell
load
fluorogen
substrat
particl
exhibit
signific
increas
entri
compar
ancestr
ebov
gp
figur
contrast
decreas
entri
measur
mutant
gp
increas
infect
primat
cell
cell
speci
next
determin
whether
infecti
cell
permiss
speci
whether
increas
infect
humanspecif
adapt
main
cellular
receptor
ebov
carett
et
al
et
al
ebov
gpinteract
region
well
defin
gong
et
al
krishnan
et
al
wang
et
al
ebov
interact
loop
posit
close
proxim
ebov
assess
speciesspecif
amino
acid
differ
within
portion
mammalian
speci
figur
tabl
ebov
interact
loop
almost
perfectli
conserv
primat
figur
two
speci
new
world
monkey
callithrix
jacchu
lemur
microcebu
murinu
harbor
amino
acid
differ
found
human
callithrix
jacchu
microcebu
murinu
outsid
primat
nearli
speci
nonpolar
amino
acid
residu
except
rabbit
oryctolagu
cuniculu
glutamin
sever
speci
harbor
amino
acid
chang
residu
previou
studi
shown
dtof
substitut
residu
disrupt
interact
ebov
gp
straw
color
fruit
bat
eidolon
helvum
ng
et
al
like
similar
substitut
would
prevent
ebov
infect
killer
whale
orcinu
orca
pig
su
scrofa
jamaican
fruit
bat
artibeu
jamaicensi
possibl
common
vampir
bat
desmodu
rotundu
base
sequenc
align
anticip
infect
use
ebov
variant
nonhuman
primat
cell
would
result
similar
enhanc
seen
human
cell
test
predict
transduc
cell
sever
primat
speci
well
carnivor
rodent
gfpexpress
lentivir
vector
pseudotyp
ebov
gp
inde
cell
nonhuman
primat
suscept
infect
figur
contrast
cell
rodent
carnivor
show
differ
infect
western
blot
top
enrich
lentivir
particl
pseudotyp
ctermin
ebov
gp
probe
antibodi
bar
graph
show
ebov
signal
intens
rel
observ
correspond
lentivir
capsid
b
data
point
repres
normal
transduct
use
lentivir
stock
deriv
independ
transfect
c
data
point
repres
independ
experi
four
independ
viral
stock
eight
differ
human
donor
p
p
p
repeatedmeasur
anova
dunnett
posttest
compar
ancestr
ebov
gp
ancestr
ebov
gp
result
demonstr
provid
primatespecif
enhanc
infect
homolog
model
use
examin
ebov
loop
domain
ortholog
mammalian
speci
test
herea
well
bat
speci
potenti
ebov
reservoirsmay
alter
virushost
interact
figur
ebov
mutat
locat
helix
directli
interact
loop
figur
though
residu
locat
back
side
helix
term
like
affect
viral
gp
model
suggest
mutat
littl
impact
helix
backbon
rather
addit
alkan
branch
side
chain
valin
compar
alanin
may
differenti
impact
neighbor
amino
acid
arginin
residu
figur
extend
charg
pocket
present
opposit
side
helix
interact
occur
nitrogen
termin
guanidinium
group
like
form
ionic
interact
sidechain
backbon
hydroxyl
group
host
side
sever
amino
acid
differ
loop
domain
among
mammal
like
impact
filoviru
suscept
speciesspecif
manner
zhao
et
al
specif
lysin
found
residu
primat
speci
examin
possess
nonpolar
residu
sever
speci
includ
mous
dog
possess
tyrosin
place
phenylalanin
figur
determin
whether
mutat
detect
effect
viremia
mortal
obtain
ebov
genotyp
data
locat
guinea
liberia
sierra
leon
aria
et
al
carrol
et
al
gire
et
al
kugelman
et
al
ladner
et
al
park
et
al
quick
et
al
simonlorier
et
al
tong
et
al
mortal
viral
load
inform
also
avail
data
recapitul
skew
seen
ebov
gp
genotyp
preval
per
countri
depict
figur
figur
analysi
restrict
case
data
avail
regard
four
paramet
viral
load
mortal
sampl
locat
viral
genotyp
carrol
et
al
gire
et
al
quick
et
al
case
occur
guinea
analysi
restrict
guinea
sampl
district
pare
data
geograph
differ
preval
viral
genotyp
remain
figur
examin
associ
viral
load
assess
c
valu
risk
death
allel
found
viral
load
possess
significantli
associ
higher
mortal
lower
c
valu
correspond
higher
viral
load
highli
predict
neg
outcom
figur
consist
previou
report
de
la
vega
et
al
li
et
al
individu
slightli
higher
viral
load
lower
c
valu
figur
differ
statist
signific
student
test
mean
mean
v
ci
differ
mean
p
valu
infect
viru
associ
significantli
higher
risk
death
raw
odd
ratio
ci
figur
better
understand
associ
mortal
model
fatal
rate
ancestr
genotyp
rang
viral
load
transform
c
valu
figur
correct
differ
c
valu
adjust
odd
ratio
remain
wide
confid
interv
ci
ad
multipl
potenti
confound
factor
includ
geograph
variat
base
fatal
rate
access
health
care
model
littl
effect
conclus
found
modest
evid
geograph
variat
figur
includ
cumul
number
evd
case
per
region
proxi
evdassoci
burden
health
care
infrastructur
fail
improv
model
fit
figur
taken
togeth
data
suggest
increas
risk
death
peopl
infect
rule
independ
effect
mutat
demonstr
associ
causal
devast
evd
epidem
led
two
order
magnitud
case
previou
evd
outbreak
cdc
provid
greater
opportun
ebov
undergo
human
adapt
chang
ever
mutat
ebov
makona
gp
aros
earli
outbreak
nearli
replac
ancestr
genotyp
present
virus
respons
viruslik
particl
vlp
gener
ebov
fusion
protein
either
ancestr
ebov
gp
one
indic
mutant
cell
incub
vlpcontain
supernat
hr
c
hr
c
load
overnight
c
cleavag
measur
use
fluoresc
plate
reader
excit
emiss
filter
signal
cleav
signal
ebov
gp
compar
observ
ancestr
ebov
gp
data
mean
sem
n
viral
infect
repres
experi
p
p
p
ns
p
oneway
anova
burnett
posttest
compar
ancestr
ebov
gp
major
evd
case
epidem
figur
data
show
enhanc
infect
human
primat
cell
cell
mammalian
speci
figur
given
locat
bind
interfac
left
strong
suspicion
repres
ebov
adapt
human
host
human
popul
data
reveal
modest
trend
toward
higher
viremia
signific
associ
increas
mortal
figur
rais
intrigu
possibl
phenotyp
result
mutat
cosubmit
manuscript
urbanowicz
colleagu
independ
arriv
conclus
enhanc
viral
infect
human
cell
urbanowicz
et
al
hand
enhanc
infect
within
context
numer
gp
sequenc
observ
outbreak
complementari
find
show
decreas
infect
varieti
bat
cell
line
speci
amino
acid
substitut
bind
loop
similar
nonprim
speci
test
figur
data
support
hypothesi
primatespecif
adapt
molecular
data
warrant
followup
vivo
highcontain
experi
revers
genet
system
use
studi
live
ebov
variant
data
mean
sem
n
data
point
repres
infect
use
independ
viral
stock
p
repeatedmeasur
anova
dunnett
posttest
compar
ancestr
ebov
gp
see
also
tabl
volchkov
et
al
use
headtohead
comparison
variant
cell
culturebas
assay
et
al
moreov
although
human
clinic
data
show
associ
higher
case
fatal
rate
control
experi
could
test
whether
causal
clinic
phenotyp
higher
viral
load
nonhuman
primat
mutat
enhanc
infect
human
cell
gpmediat
fusion
figur
suggest
biolog
plausibl
mechan
crossspeci
viral
adapt
emerg
human
viral
diseas
reservoir
host
major
rout
viru
transmiss
document
human
immunodefici
virus
type
sever
acut
respiratori
viru
coronaviru
sarscov
influenza
viru
dengu
viru
nipah
viru
hendra
viru
marburg
viru
parrish
et
al
share
coevolutionari
histori
zoonot
virus
thought
replic
transmit
effici
reservoir
host
human
new
host
although
product
infect
may
occur
differ
key
host
factor
cell
reservoir
versu
new
host
impair
import
event
receptor
bind
entri
replic
viral
genom
virion
assembl
releas
avoid
host
innat
adapt
immun
respons
effici
receptor
util
new
host
common
rout
adapt
describ
sar
cov
li
et
al
numer
influenza
strain
herfst
et
al
imai
et
al
matrosovich
et
al
steven
et
al
steven
et
al
xu
et
al
experiment
find
involv
influenza
allow
inform
surveil
anim
reservoir
well
provid
better
understand
ongo
viral
evolut
human
dugan
et
al
holm
et
al
nelson
et
al
obenau
et
al
rambaut
et
al
russel
et
al
knowledg
ebov
gp
mutat
modul
fusion
host
cell
may
rout
human
adapt
gp
residu
mediat
adapt
potenti
valuabl
knowledg
surveil
activ
futur
ebov
epidem
mutat
backsid
helix
interact
therefor
predict
littl
direct
impact
bind
howev
like
differ
alanin
valin
side
chain
pack
neighbor
amino
acid
valin
contain
alkan
branch
alanin
would
place
side
chain
closer
proxim
steric
hindranc
may
alter
predict
salt
bridg
apart
figur
addit
ad
bulk
mutat
may
alter
helix
conform
provid
better
access
proxim
resid
interact
compar
human
loop
domain
inclus
hydrophob
side
chain
site
valin
isoleucin
mammal
nonprim
probabl
add
bulk
near
backbon
potenti
restrict
loop
adapt
new
conform
primat
also
possess
phenylalanin
amino
acid
sever
speci
tyrosin
chang
phenylalanin
tyrosin
common
differ
ortho
hydrogen
phenylalanin
hydroxyl
group
tyrosin
benzen
ring
gener
nonreact
rare
involv
protein
function
howev
predict
make
contact
eight
residu
ebov
gp
measur
distanc
potenti
critic
site
filoviru
suscept
addit
effect
substitut
could
impart
interact
may
also
alter
plot
c
show
mean
box
cover
second
third
quartil
sampl
bar
mark
quantil
dot
repres
sampl
outsid
probabl
region
e
mortal
data
individu
infect
ebov
encod
either
ancestr
gp
f
depict
correl
gp
genotyp
mortal
base
result
binomi
gener
linear
model
use
c
valu
gp
genotyp
covari
predict
case
fatal
rate
rang
viral
load
depict
transform
c
valu
c
valu
transform
subtract
mean
divid
two
standard
deviat
flip
sign
valu
graph
correspond
averag
c
valu
transform
variabl
reflect
viral
load
see
also
figur
propens
ebov
gp
undergo
trigger
upon
interact
context
trigger
process
refer
dramat
conform
chang
undertaken
ebov
gp
result
exposur
viral
fusion
peptid
normal
sequest
adapt
human
remain
open
question
whether
chang
led
increas
replic
human
host
also
increas
transmiss
human
mutat
first
sampl
march
data
approxim
evd
case
cdc
data
show
increas
infect
ebov
varieti
human
cell
tissu
cultur
associ
increas
mortal
human
although
signific
question
remain
find
rais
possibl
mutat
contribut
directli
greater
transmiss
thu
sever
outbreak
difficult
draw
conclus
hypothesi
though
sinc
frequenc
increas
also
attribut
stochast
effect
includ
founder
effect
ebov
move
guinea
sierra
leon
multipl
reintroduct
back
guinea
case
earli
emerg
highlight
need
vigor
surveil
rapid
public
health
intervent
identif
evd
emerg
infecti
diseas
order
limit
possibl
viral
adapt
human
final
studi
necessari
provid
vital
biolog
inform
crucial
interpret
viral
sequenc
evolut
connect
viral
genotyp
phenotyp
maxim
util
viral
sequenc
effort
outbreak
allow
effici
target
intervent
strategi
detail
method
provid
onlin
version
paper
includ
follow
wed
ael
ar
mg
kga
pc
jl
design
supervis
studi
wed
ael
ndg
lmc
kk
ppk
smm
sf
ed
ak
pm
mg
kga
conduct
experi
collect
dataset
author
analyz
data
wrote
manuscript
ucl
london
uk
cell
line
test
verifi
absenc
mycoplasma
assay
perform
verifi
ident
cell
cultur
follow
receipt
cell
peripher
blood
mononuclear
cell
pbmc
isol
deidentifi
healthi
donor
leukopak
new
york
biolog
southampton
ny
accord
ummsirb
protocol
id
deem
cell
nonhuman
subject
research
publicli
avail
ebov
makona
genom
download
niaid
viru
pathogen
databas
analysi
resourc
vipr
pickett
et
al
access
http
wwwviprbrcorg
juli
n
tabl
sequenc
ambigu
miss
nucleotid
call
remov
high
qualiti
dataset
sequenc
creat
compris
codingcomplet
genom
tabl
sequenc
align
mafft
katoh
standley
follow
paramet
linsi
localpairmaxiter
nucleotid
align
use
phylogenet
analys
trim
use
trimal
rrez
et
al
maximum
likelihood
specif
paramet
align
amino
acid
sequenc
ebov
makona
gp
also
perform
mafft
relev
align
found
data
maximum
likelihood
phylogeni
made
raxml
stamataki
et
al
use
gtrg
nucleotid
substitut
model
fifti
consecut
run
perform
tree
best
likelihood
score
bootstrap
pseudorepl
root
tree
ebov
makona
sequenc
guinea
align
ebov
mayinga
variant
outgroup
identifi
earliest
sequenc
evd
epidem
like
root
tree
data
subsequ
tree
root
accord
analysi
data
cell
maintain
c
co
humidifi
incub
crfk
mdtf
maintain
dmem
supplement
fb
maintain
amem
supplement
fb
vero
maintain
emem
supplement
fb
maintain
dmem
supplement
fb
hepe
ph
ad
medium
formul
final
concentr
mm
mononuclear
leukocyt
isol
gradient
centrifug
sigmaaldrich
st
loui
mo
mononuclear
cell
enrich
via
posit
select
use
antibodi
microbead
conjug
miltenyi
san
diego
ca
accord
manufactur
protocol
cell
plate
densiti
cellsml
supplement
heat
inactiv
human
ab
serum
omega
scientif
tarzana
ca
mm
lglutamin
thermofish
waltham
mm
hepe
ph
sigmaaldrich
mm
sodium
pyruv
thermofish
x
mem
nonessenti
amino
acid
thermofish
differenti
monocyt
dendrit
cell
mddc
promot
addit
recombin
human
gmcsf
human
cytokin
produc
cell
stabli
transduc
paiphgmcsfco
respect
previous
describ
reinhard
et
al
cytokin
supernat
ad
dilut
plasmid
dna
ebola
viru
glycoprotein
guinean
refer
strain
genbank
synthes
gblock
integr
dna
technolog
coralvil
ia
engin
lack
mucin
domain
amino
acid
chandran
et
al
contain
addit
adenosin
nucleotid
modif
substitut
transcript
edit
bona
fide
ebov
use
produc
fulllength
glycoprotein
sanchez
et
al
sequenc
contain
flank
ncoi
xbai
restrict
enzym
site
clone
mammalian
express
vector
control
cytomegaloviru
immedi
earli
cmv
ie
promot
enhanc
construct
singl
amino
acid
substitut
well
doubl
tripl
amino
acid
substitut
gener
quikchang
mutagenesi
agil
technolog
santa
clara
ca
substitut
phusion
highfidel
pcr
master
mix
gc
buffer
new
england
biolab
ipswich
follow
primer
util
gener
mutat
f
r
f
ccggttttggaactaatgaggcagagtacttgttc
r
f
gataaaacccttccgggc
r
addit
deriv
ancestr
mutant
glycoprotein
gener
remov
stop
codon
f
ctgtatatgcaaat
r
insert
xbaiflank
ctermin
tag
synthes
gblock
integr
dna
technolog
addit
c
valu
absencepres
mutat
genotyp
order
make
coeffici
estim
consist
continu
variabl
binari
variabl
standard
continu
variabl
subtract
mean
divid
two
standard
deviat
gelman
facilit
interpret
result
flip
sign
result
variabl
consist
viral
load
invers
relat
c
assess
effect
potenti
confound
variabl
fit
varyingintercept
also
call
random
effect
model
data
assign
locat
intercept
use
glmer
function
packag
bate
et
al
amount
state
locat
allow
baselin
fatal
rate
also
allow
locat
coeffici
cumcas
variabl
structur
model
allow
variabl
locat
respond
demand
health
care
explor
model
show
associ
sampl
date
outcom
variabl
subsequ
drop
model
estim
model
includ
c
valu
genotyp
fix
effect
cumcas
vari
effect
present
figur
show
consider
uncertainti
thu
decid
make
infer
base
simpler
model
use
fix
effect
variabl
c
genotyp
comparison
c
valu
per
genotyp
perform
use
student
test
use
data
c
valu
genotyp
inform
avail
regardless
outcom
inform
obtain
c
measur
genotyp
measur
genotyp
result
report
main
text
indic
signific
associ
viral
load
measur
c
genotyp
analys
carri
r
r
core
team
figur
produc
use
packag
wickham
determin
ebola
viru
gp
incorpor
viral
particl
cell
transfect
accord
procedur
substitut
plasmid
encod
ctermin
ebola
viru
gp
correspond
untag
version
construct
inde
phenotyp
untag
construct
data
shown
hr
media
chang
viral
supernat
harvest
pass
filter
layer
sucros
cushion
viru
pellet
sucros
cushion
spin
x
g
use
bucket
optima
ultracentrifug
beckman
coulter
indianapoli
supernat
remov
viral
pellet
gentli
wash
ml
ice
cold
pb
viru
lyse
hypoton
lysi
buffer
mm
trishcl
ph
mm
nacl
mm
edta
triton
complet
mini
proteas
inhibitor
sigmaaldrich
st
loui
mo
concomitantli
transfect
cell
wash
ice
cold
pb
lyse
hypoton
lysi
buffer
min
ice
clarifi
centrifug
x
g
min
c
cell
lysat
supernat
transfer
new
tube
insolubl
pellet
discard
prepar
sdspage
fraction
viral
cellular
lysat
mix
laemmli
buffer
contain
mm
boil
min
prepar
sampl
run
gradient
sdspage
gel
transfer
nitrocellulos
membran
membran
block
well
primari
secondari
antibodi
bind
perform
use
tb
odyssey
block
buffer
licor
lincoln
ne
accord
manufactur
instruct
tag
detect
use
rabbit
polyclon
serum
novu
biolog
littleton
co
dilut
lentivir
ca
detect
use
mous
monoclon
antibodi
chesebro
et
al
dilut
imag
licor
odyssey
clx
system
licor
primari
antibodi
recogn
goat
goat
licor
dilut
blot
scan
resolut
mm
use
medium
qualiti
set
quantit
specif
band
done
use
box
tool
odyssey
softwar
packag
background
subtract
perform
use
pixel
immedi
adjac
box
refer
background
level
threedimension
protein
structur
analysi
targettempl
align
compar
homolog
model
human
bound
ebov
gpcl
experiment
deriv
protein
data
bank
access
number
pdb
target
loop
amino
acid
substitut
perform
use
icmpro
version
molsoft
san
diego
ca
abagyan
et
al
experiment
n
valu
inform
regard
refer
found
figur
legend
viral
infect
data
cell
line
independ
assess
statist
signific
use
repeatedmeasur
anova
valu
obtain
uniqu
viral
stock
variabl
consid
repeatedmeasur
repeatedmeasur
anova
dunnett
posttest
multipl
comparison
appli
infect
deriv
gp
compar
ancestr
gp
ebov
vlp
fusion
data
assess
statist
signific
use
oneway
anova
bartlett
posttest
compar
deriv
gp
ancestr
gp
anova
perform
use
prism
softwar
graphpad
softwar
la
jolla
ca
figur
varyingintercept
model
fatal
rate
relat
figur
fit
model
allow
locat
base
fatal
rate
ie
intercept
also
slope
cumul
case
cumcas
variabl
order
account
heterogen
locat
respond
demand
healthcar
find
variabl
data
possibl
rel
small
number
observ
lead
broad
estim
model
paramet
seem
differ
base
fatal
rate
forecariah
nzerekor
exampl
overlap
confid
interv
preclud
definit
conclus
